Showing results (1561-1570 of 1,927) with videos related to

Sort By:
Pageof 193
Molecular Cancer Research : MCR|June 26, 2023
Allele-Specific Gene Regulation, Phenotypes, and Therapeutic Vulnerabilities in Estrogen Receptor Alpha-Mutant Endometrial CancerZannel Blanchard, Craig M Rush, Spencer Arnesen, et al.
Scientific Reports|October 25, 2017
Canonical NFκB signaling in myeloid cells is required for the glioblastoma growthB R Achyut, Kartik Angara, Meenu Jain, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2001
Dorsal subthalamotomy for Parkinson's diseaseL Alvarez, R Macias, J Guridi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2001
An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV)P E Castle, S L Hillier, L K Rabe, et al.
Cell Cycle (Georgetown, Tex.)|August 3, 2007
ErbB-2 induces bilateral adrenal pheochromocytoma formation in miceEdwin W Lai, Olga C Rodriguez, Maral Aventian, et al.
Heart Rhythm|March 8, 2007
Differentiation of ventricular and supraventricular tachycardias based on the analysis of the first postpacing interval after sequential anti-tachycardia pacing in implantable cardioverter-defibrillator patientsAngel Arenal, Mercedes Ortiz, Rafael Peinado, et al.
British Journal of Cancer|July 25, 2014
Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study)M Quintela-Fandino, A Urruticoechea, J Guerra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Navigating the highlights of phase III trials: a watchful eye on evidence-based radiotherapyJ C Trone, S Espenel, A Rehailia-Blanchard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancersAndrew Berchuck, Joellen M Schildkraut, Robert M Wenham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancerJ C Osorio, A Ni, J E Chaft, et al.
Pageof 193